Identification of essential genes for cancer immunotherapy SJ Patel, NE Sanjana, RJ Kishton, A Eidizadeh, SK Vodnala, M Cam, ... Nature 548 (7669), 537-542, 2017 | 802 | 2017 |
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response CN Spencer, JL McQuade, V Gopalakrishnan, JA McCulloch, M Vetizou, ... Science 374 (6575), 1632-1640, 2021 | 414 | 2021 |
UVB-induced tumor heterogeneity diminishes immune response in melanoma Y Wolf, O Bartok, S Patkar, GB Eli, S Cohen, K Litchfield, R Levy, ... Cell 179 (1), 219-235. e21, 2019 | 323 | 2019 |
Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells D Tormo, A Chęcińska, D Alonso-Curbelo, E Pérez-Guijarro, E Cañón, ... Cancer cell 16 (2), 103-114, 2009 | 228 | 2009 |
RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway D Alonso-Curbelo, E Riveiro-Falkenbach, E Pérez-Guijarro, M Cifdaloz, ... Cancer cell 26 (1), 61-76, 2014 | 116 | 2014 |
Genetically engineered mouse models of melanoma E Pérez‐Guijarro, CP Day, G Merlino, MR Zaidi Cancer 123 (S11), 2089-2103, 2017 | 93 | 2017 |
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy E Pérez-Guijarro, HH Yang, RE Araya, R El Meskini, HT Michael, ... Nature medicine 26 (5), 781-791, 2020 | 90 | 2020 |
Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis KL Marie, A Sassano, HH Yang, AM Michalowski, HT Michael, T Guo, ... Nature Communications 11 (1), 333, 2020 | 66 | 2020 |
p62/SQSTM1 fuels melanoma progression by opposing mRNA decay of a selective set of pro-metastatic factors P Karras, E Riveiro-Falkenbach, E Cañón, C Tejedo, TG Calvo, ... Cancer Cell 35 (1), 46-63. e10, 2019 | 57 | 2019 |
Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers E Pérez-Guijarro, P Karras, M Cifdaloz, R Martínez-Herranz, E Cañón, ... Nature communications 7 (1), 13418, 2016 | 48 | 2016 |
PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problem E Sadeqi Azer, F Rashidi Mehrabadi, S Malikić, XC Li, O Bartok, ... Bioinformatics 36 (Supplement_1), i169-i176, 2020 | 18 | 2020 |
A role for insulator elements in the regulation of gene expression response to hypoxia M Tiana, D Villar, E Perez-Guijarro, L Gomez-Maldonado, E Molto, ... Nucleic acids research 40 (5), 1916-1927, 2012 | 17 | 2012 |
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response M Pagadala, TJ Sears, VH Wu, E Pérez-Guijarro, H Kim, A Castro, ... Nature communications 14 (1), 2744, 2023 | 10 | 2023 |
Recognition of observer effect is required for rigor and reproducibility of preclinical animal studies CP Day, E Pérez-Guijarro, A Lopès, RS Goldszmid, M Murgai, ... Cancer Cell 40 (3), 231-232, 2022 | 10 | 2022 |
Profiles of expressed mutations in single cells reveal subclonal expansion patterns and therapeutic impact of intratumor heterogeneity FR Mehrabadi, KL Marie, E Pérez-Guijarro, S Malikić, ES Azer, HH Yang, ... bioRxiv, 2021.03. 26.437185, 2021 | 9 | 2021 |
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities A Karz, M Dimitrova, K Kleffman, C Alvarez‐Breckenridge, MB Atkins, ... Pigment cell & melanoma research 35 (6), 554-572, 2022 | 8 | 2022 |
Lymphangiogenesis: from passive disseminator to dynamic metastatic enabler E Pérez-Guijarro, G Merlino Pigment cell & melanoma research 30 (6), 509, 2017 | 4 | 2017 |
Comprehensive single-cell transcriptomic analysis of embryonic melanoblasts uncovers lineage-specific mechanisms of melanoma metastasis and therapy resistance V Gopalan, CP Day, E Pérez-Guijarro, S Chin, J Ebersole, C Smith, ... bioRxiv, 2022.10. 14.512297, 2022 | 3 | 2022 |
Fast intratumor heterogeneity inference from single-cell sequencing data C Kızılkale, F Rashidi Mehrabadi, E Sadeqi Azer, E Pérez-Guijarro, ... Nature computational science 2 (9), 577-583, 2022 | 2 | 2022 |
Germline variants that influence the tumor immune microenvironment also drive response to immunotherapy M Pagadala, VH Wu, E Pérez-Guijarro, H Kim, A Castro, J Talwar, ... BioRxiv, 2021 | 2 | 2021 |